Back to top
more

Varian Medical Systems, Inc. (VAR)

(Delayed Data from NYSE)

$139.13 USD

139.13
380,711

+1.32 (0.96%)

Updated May 3, 2019 04:00 PM ET

After-Market: $139.16 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Varian (VAR) Inks Deal With Google Cloud to Boost Cancer Care

by Zacks Equity Research

Varian (VAR) partners with Google Cloud to help in the fight against cancer through the development of an advanced AI based diagnostic platform.

    Varian Medical (VAR) Hits 52-Week High: What's Driving It?

    by Zacks Equity Research

    Varian Medical (VAR) is optimistic about its prospective acquisitions and strength in Proton Therapy segment.

    Should JPMorgan Diversified Return U.S. Mid Cap Equity ETF (JPME) Be on Your Investing Radar?

    by Zacks Equity Research

    Style Box ETF report for JPME

    Why You Should Retain Varian (VAR) in Your Portfolio Now

    by Zacks Equity Research

    Investor optimism is high on the Varian (VAR) stock, courtesy of its solid prospects.

    Is JPMorgan Diversified Return U.S. Mid Cap Equity ETF (JPME) a Strong ETF Right Now?

    by Zacks Equity Research

    Smart Beta ETF report for JPME

    Varian (VAR) Q1 Earnings Beat Estimates, Revenues Miss Mark

    by Zacks Equity Research

    Varian's (VAR) receipt of 13 Ethos orders in fiscal Q1 raises investors' optimism on the stock.

    Varian Medical Systems, Inc. (VAR) Beats Q1 Earnings Estimates

    by Zacks Equity Research

    Varian Medical Systems, Inc. (VAR) delivered earnings and revenue surprises of 9.62% and -8.33%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

    Varian (VAR) to Report Q1 Earnings: What's in the Offing?

    by Zacks Equity Research

    Varian's (VAR) fiscal first-quarter earnings are likely to reflect strength in Halcyon platform.

    Varian (VAR) Inks Deal With Yonsei Cancer Center in Korea

    by Zacks Equity Research

    Varian (VAR) will be coordinating with Yonsei Cancer Center on formulating AI solutions, which are proven to upgrade early detection of cancer.

    Here's Why You Should Hold onto Varian Medical (VAR) Stock Now

    by Zacks Equity Research

    Investor confidence is high on Varian Medical (VAR) stock, courtesy of solid prospects.

    Is JPMorgan Diversified Return U.S. Mid Cap Equity ETF (JPME) a Strong ETF Right Now?

    by Zacks Equity Research

    Smart Beta ETF report for JPME

    Urmimala Biswas headshot

    3 Best Buys from the Prospering Medical Instruments Industry

    by Urmimala Biswas

    Despite the challenges posed by the COVID-19 pandemic, higher demand for lab-testing products, digital influence, and AI and robotics is likely to lend support to the Zacks Medical - Instruments industry. TMO, IDXX and STE are well positioned to gain.

    Is JPMorgan Diversified Return U.S. Mid Cap Equity ETF (JPME) a Strong ETF Right Now?

    by Zacks Equity Research

    Smart Beta ETF report for JPME

    Varian (VAR) Earnings and Revenues Surpass Estimates in Q4

    by Zacks Equity Research

    Varian's (VAR) receipt of 10 Ethos orders in Q4 instills optimism

    Varian (VAR) to Report Q4 Earnings: What's in the Offing?

    by Zacks Equity Research

    Varian's (VAR) solid Oncology platform is expected to have driven fiscal fourth-quarter performance.

      Is JPMorgan Diversified Return U.S. Mid Cap Equity ETF (JPME) a Strong ETF Right Now?

      by Zacks Equity Research

      Smart Beta ETF report for JPME

      Sweta Killa headshot

      5 Stocks in S&P 500 ETF That Have Powered Best Q3 Since 2010

      by Sweta Killa

      The S&P 500 was up 8.5% in the third quarter, representing its best back-to-back quarter since 2009.

      Is JPMorgan Diversified Return U.S. Mid Cap Equity ETF (JPME) a Strong ETF Right Now?

      by Zacks Equity Research

      Smart Beta ETF report for JPME

      Varian (VAR) Expands Presence With Germany's Ethos Order

      by Zacks Equity Research

      Varian's (VAR) Ethos therapy is being adopted in Germany, thus expanding the company's geographic footprint.

      Varian Expands Access to Advanced Cancer Treatment With Ethos

      by Zacks Equity Research

      Varian's (VAR) Ethos Therapy used by Goshen Center for Cancer Care marks the expansion access to personalized cancer care.

      Varian's Halcyon System to Bring Improved Care to Singapore

      by Zacks Equity Research

      Varian (VAR) strengthens its partnership Proton Therapy Pte as it brings improved care to Singapore through Halcyon system.

      Urmimala Biswas headshot

      MedTech Lifts S&P 500 Index: 3 Stocks With Upside Potential

      by Urmimala Biswas

      MedTech stocks play a major role in holding the index up and ending the shortest bear run in the history of S&P 500.

      Why Hold Strategy is Apt for Varian Medical (VAR) Stock Now

      by Zacks Equity Research

      Investor confidence is high in Varian Medical (VAR) stock at the moment.

      Varian (VAR) Earnings and Revenues Surpass Estimates in Q3

      by Zacks Equity Research

      Varian's (VAR) Proton Solutions unit saw revenue growth in Q3.

      Urmimala Biswas headshot

      Medical Products Stock Earnings on Aug 5: RMD, ABC & More

      by Urmimala Biswas

      Many Medical Product stocks might have succeeded in mitigating coronavirus-led downsides banking on huge market adoption of their COVID-19-related healthcare-support products in the second quarter.